Ulcerative colitis (moderate to severely active) - vedolizumab [ID691]: Evaluation report part 2
Table of contents:
Evaluation report part 2 (pdf file)
03 - NICE request to the manufacturer for clarification on their submission
![Ulcerative colitis (moderate to severely active) - vedolizumab [ID691]: Evaluation report part 2](/proxy/?sourceUrl=http%3a%2f%2fwww.nice.org.uk%2fimages%2ficons%2fpdf.gif)
|
Ulcerative colitis (moderate to severely active) - vedolizumab [ID691]: Evaluation report part 2
26 November 2014 (5.23 Mb 26 mins ) |
This page was last updated: 25 November 2014